MONITORING OF EXPRESSION OF ONCOMARKERS IN CANCER AND PRE-CANCER OF THE RECTUM


  • L.N. Vasko Ukrainian Medical Stomatological Academy, Ukraine
  • T.A. Zhukova
  • E.I. Nestulia
DOI: https://doi.org/10.29256/v.02.02.2018.escbm56
Keywords: cancer, pre-cancer, rectal cancer, oncomarkers.

Abstract

MONITORING OF EXPRESSION OF ONCOMARKERS IN CANCER AND PRE-CANCER OF THE RECTUM

References

1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–1403.

2. Couzin-Frankel J. Breakthrough of the year 2013. Cancer immunotherapy. Science. 2013:342;1432-1433.

3. Fukuyama T, Yamazaki T, Fujita T, et al. Helicobacter pylori, a carcinogen, induces the expression of melanoma antigen- encoding gene (Mage)-A3, a cancer/testis antigen. Tumor Biol. 2012;33:1881-1887.

4. Yang J, Li ZH, Zhou JJ, et al. Preparation and antitumor effects of nanovaccines with MAGE-3 peptides in transplanted gastric cancer in mice. Chin J Cancer. 2010;29: 359-364.

5. Masuzawa T, Fujiwara Y, Okada K, et al. Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer. Int J Oncol. 2012;41:1297-1304.
Published
2018-11-15
How to Cite
Vasko, L., Zhukova, T., & Nestulia, E. (2018). MONITORING OF EXPRESSION OF ONCOMARKERS IN CANCER AND PRE-CANCER OF THE RECTUM. Biological Markers in Fundamental and Clinical Medicine (scientific Journal), 2(2), 65-66. https://doi.org/10.29256/v.02.02.2018.escbm56
Issue
Vol 2 No 2 (2018): BIOLOGICAL MARKER
Section
Selected abstracts
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.